MeSH tree: N02.421.726.233
Rapidly aging populations and rising cases of lifestyle-related diseases (LRDs), like diabetes and hypertension, are driving significant financial strain on government budgets. While regular health checkups under a standardized ...
Sep 29, 2025
0
9
A new international study led by Mayo Clinic researchers has identified a genetic factor that may explain why some patients with colorectal cancer that has spread to the liver experience more severe liver damage after chemotherapy.
Sep 29, 2025
0
12
Mayo Clinic researchers have developed a genetic test that can help predict how people will respond to weight loss medications such as GLP-1s.
Sep 18, 2025
0
26
A new study has found that trust in researchers is the strongest factor influencing whether older adults are willing to participate in Alzheimer's disease and related dementia (ADRD) biomarker research. In a survey of 399 ...
Sep 15, 2025
0
15
Researchers from Children's Hospital of Philadelphia (CHOP) and the Clinic for Special Children found that complement factor I (CFI) deficiency, an ultra-rare genetic disorder that can cause debilitating neuroinflammation, ...
Aug 13, 2025
0
19
Depression and anxiety are the most common psychiatric disorders in the world. Around 300 million people suffer from depression, whereas 301 million have anxiety disorder. That's nearly 8% of the global population. Unfortunately, ...
Jun 30, 2025
0
14
The connections a baby's brain forms during the first two years of life, coupled with a baby's genetic makeup, offer a window into their development. Cedars-Sinai pediatric neurologists, developmental neuroscientists and ...
Jun 20, 2025
0
113
For decades, gynecologic cancer treatment has used aggressive surgical intervention and chemotherapy. These methods often harmed fertility. They also caused severe side effects and an uncertain prognosis.
Jun 3, 2025
0
14
A collaborative team of researchers from Children's Hospital of Philadelphia (CHOP) found that hematopoietic stem cell transplantation (HSCT) is a highly effective method for treating patients with monogenic inflammatory ...
May 21, 2025
0
14
Regeneron Pharmaceuticals said Monday it will buy genetic testing company 23andMe out of bankruptcy for $256 million, a deal that provides the US biotech company with data on millions of clients.
May 19, 2025
0
20
